Project 2: Tau uptake mechanisms and neuronal excitability in FTD
Project 2: Tau uptake mechanisms and neuronal excitability in FTD
批准号:
10011930
负责人:
KENNETH Stephen KOSIK
金额:
$29.61万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2023-02-28
关键词:
Action PotentialsAddressAffectAnticodonAstrocytesAxonBackBindingCRISPR interferenceCaliforniaCategoriesCell LineCellsCellular StressCharacteristicsCollaborationsCollectionComputer softwareCultured CellsDataDefectDendritesDetectionDevicesElectrophysiology (science)EnzymesEventFunctional disorderFutureGAG GeneGene ExpressionGenesGerm CellsGrowthHarvestHeparan Sulfate ProteoglycanHumanInstitutesInvestigationLabelLeadLinkMeasuresMediatingMethodsMicroarray AnalysisNeuronsPathogenicityPathologicPathologyPathway interactionsPatternPhenotypePhysicsPolysaccharidesPopulationPreparationProcessRNAResolutionRestRoleSignal TransductionSmall RNAStressSystemTechniquesTechnologyTestingTimeTrainingTransfer RNATranslationsanalytical toolbasecollaborative approachdesigndifferential expressionfallsinduced pluripotent stem cellinstrumentationinterestmembermillisecondmulti-electrode arraysneuronal excitabilitynovelprogramsproteostasisrelating to nervous systemsingle-cell RNA sequencingsmall moleculestress granuletau Proteinstau aggregationtau conformationtau mutationtooltranscriptome sequencingtranscriptomicsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT — PROJECT 2
Many unknown pathogenic steps lie between normal tau protein in a healthy neuron and the cellular
dysfunction that occurs as a result of tau uptake and aggregation. The aims address two emerging facets of
the pathobiology: the mechanism of tau uptake in neurons and astrocytes and the effects of tau inclusions on a
set of functional cellular parameters. Tau uptake will be studied using a highly novel and highly collaborative
approach called CRISPRi to identify in a nonbiased manner genes involved in tau uptake followed by
functional studies, which will validate the CRISPRi hits. A more focused approach to uptake will focus on
HSPGs with a GAG microarray panel to identify HSPG chain features to which tau can bind specifically. Once
tau is inside the cell we ask what are the effects of tau inclusions or tau mutations in human iPSCderived
neurons. We have synthesized multiple types of tau aggregates and studied their uptake conditions. A variety
of techniques will be applied to pinpoint cellular defects due to the burden of tau inclusions. These techniques
fall into two categories—expression sequencing and electrophysiological assessment. With regard to the
former, the strength of our proposal is the use of single cell RNAseq to identify precisely gene expression
changes in cells with tau inclusions compared to its neighbors that do not have tau inclusions. A further
strength is the data that supports our hypothesis concerning the role of tRNA in triggering tau conformational
changes that may lead to aggregation as well as an investigation of the role of cellular stress in inducing tRNA
cleavage and the formation of half tRNAs known as tiRNAs. We have also hypothesized that tau can induce
electrophysiologic dysfunction and over the past three years in collaboration with the physics department have
built tools capable of detecting conduction deficits, alterations in the action potential at the axonal initial
segment and hyerexcitability. The detection methods utilize a multielectrode array (MEA) platform, modified
MEAs that are patterned to confine neuron growth and direct signaling between neuronal ensembles, analytical
tools for spike trains, and an automated cell harvesting device. The delineation of the effects on tau mutations
and tau inclusions on cultured cells is a cellular phenotype that is not welldescribed in the field, but will be
necessary in the future for small molecule screens. Working interchangeably with several cellular systems will
allow us to select the ideal context for each experimental question posed and explore multiple facets in a
search for taurelated cellular phenotypes. This proposal rests on strong interactions among all the team
members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel approach to restricting the spread of neurofibrillary tau
-
批准号:10327251
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2021
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
A novel approach to restricting the spread of neurofibrillary tau
-
批准号:10679282
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2021
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
A novel approach to restricting the spread of neurofibrillary tau
-
批准号:10579696
-
项目类别:
-
资助金额:$3.68万
-
财政年份:2021
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
A novel approach to restricting the spread of neurofibrillary tau
-
批准号:10478173
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2021
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
The complex interaction between Alzheimer drivers and aging
-
批准号:9708308
-
项目类别:
-
资助金额:$259.11万
-
财政年份:2020
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
The complex interaction between Alzheimer drivers and aging
-
批准号:9892174
-
项目类别:
-
资助金额:$73.24万
-
财政年份:2019
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:7634459
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2007
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:8084139
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2007
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:7879951
-
项目类别:
-
资助金额:$13.19万
-
财政年份:2007
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:7234487
-
项目类别:
-
资助金额:$14.73万
-
财政年份:2007
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:7495017
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2007
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of Cdk5 Inhibitors
-
批准号:7494512
-
项目类别:
-
资助金额:$109.01万
-
财政年份:2006
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of Cdk5 Inhibitors
-
批准号:8027745
-
项目类别:
-
资助金额:$129.45万
-
财政年份:2006
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of Cdk5 Inhibitors
-
批准号:7759560
-
项目类别:
-
资助金额:$122.95万
-
财政年份:2006
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of Cdk5 Inhibitors
-
批准号:7232690
-
项目类别:
-
资助金额:$95.11万
-
财政年份:2006
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of Cdk5 Inhibitors
-
批准号:7032032
-
项目类别:
-
资助金额:$100.13万
-
财政年份:2006
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:6723437
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2004
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Development of RNAi as Treatment for Neurodegeneration
-
批准号:6878020
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Tau Degradation Pathways
-
批准号:7118214
-
项目类别:
-
资助金额:$20.96万
-
财政年份:2004
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
Tau Degradation Pathways
-
批准号:7122182
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2004
-
负责人:KENNETH Stephen KOSIK
-
依托单位:
海外基金